PROF. ABRAHAM SHULMAN, M.D.
Medical Practice in Flushing, NY

License number
New York 081566-1
Category
Medical Practice
Type
Otology & Neurotology
Address
Address 2
118 Queens Blvd. SUITE 1430, Flushing, NY 11375
85 210 St., Jamaica, NY 11427
Phone
(718) 773-8888
(718) 465-3669 (Fax)

Personal information

See more information about ABRAHAM SHULMAN at radaris.com
Name
Address
Phone
Abraham Shulman
382 Plainview Rd, Hicksville, NY 11801
Abraham Shulman
3 Overhill Rd, Monsey, NY 10952
Abraham Shulman
8508 210Th St, Queens Village, NY 11427
Abraham Shulman
11835 Queens Blvd, Forest Hills, NY 11375
Abraham Shulman
11835 Queens Blvd F His, Brooklyn, NY 11201
(718) 773-8888

Organization information

See more information about ABRAHAM SHULMAN at bizstanding.com

ABRAHAM SHULMAN, M.D., PLLC

85-08 210 St, Queens Village, NY 11427

Registration:
Mar 19, 1998
State ID:
2240354
Business type:
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY


Abraham Shulman MD

11835 Queens Blvd, Flushing, NY 11375

Status:
Inactive
Industry:
Medical Doctor's Office
Medical Doctors:
Barbara Goldstein Otolaryngology, Phd, inactive,A. Shulman Medical Doctor, Otolaryngology, Owner, inactive,Cynthia Abraham Medical Doctor, inactive

Professional information

Abraham Shulman Photo 1

Targeted Delivery Of Pharmaceutical Compounds

US Patent:
2009022, Sep 10, 2009
Filed:
Feb 28, 2007
Appl. No.:
12/280844
Inventors:
Alfred Stracher - Roslyn NY, US
Leo Kessner - West Orange NJ, US
Abraham Shulman - Hollis Hills NY, US
International Classification:
A61K 38/05, C07C 233/47, A61P 25/28
US Classification:
514 19, 564197
Abstract:
Techniques are provided for targeting a pharmaceutically active compound using, as a carrier, a molecule (or molecules) having greater affinity for a particular site in a living organism's body than for other sites therein. A compound of the formula B-L-A is provided, where B represents the residue of a small synthetic molecule, preferably one that is approved for human use, having a greater affinity for a particular site in a patient's body than for other sites in the patient's body, L represents a direct bond or a linking group, and A represents the residue of a pharmaceutically active compound.